Table 2.
Factors associated with compliance rate among population.
| Compliance to hand washing (%) | Compliance to wearing mask (%) | Compliance to keeping safe distance (%) | Compliance to decreasing frequency of going out (%) | |
|---|---|---|---|---|
| Demographics | ||||
| Gender | ||||
| Male | 183 (46.4) | 200 (50.8) | 185 (46.9) | 187 (47.5) |
| Female | 120 (30.5) | 141 (35.8) | 119 (30.2) | 130 (32.9) |
| p-value | 0.265 | 0.812 | 0.144 | 0.93 |
| Age (years) | ||||
| Youth (18-24) | 146 (37.1) | 163 (41.4) | 135 (34.3) | 148 (37.6) |
| Adults (25-64) | 151 (38.3) | 169 (42.9) | 162 (41.2) | 158 (40.1) |
| Seniors (>64) | 6 (1.52) | 9 (2.30) | 7 (1.77) | 11 (2.79) |
| p-value | 0.179 | 0.668 | 0.003 | 0.126 |
| Countries* | ||||
| Developed | 124 (31.5) | 141 (35.8) | 139 (35.3) | 134 (34.0) |
| Developing | 179 (45.4) | 200 (50.8) | 165 (41.9) | 183 (46.4) |
| p-value | 0.240 | 0.038 | <0.001 | 0.016 |
| Income | ||||
| <Rs. 200,000/USD 4500 | 178 (45.2) | 205 (52.0) | 185 (46.9) | 191 (48.5) |
| Rs. 200,000-400,000/ USD 4500-5500 | 54 (13.7) | 60 (15.2) | 52 (13.2) | 56 (14.2) |
| >Rs. 400,000/USD 5500 | 71 (18.0) | 76 (19.3) | 67 (17.0) | 70 (17.8) |
| p-value | 0.153 | 0.493 | 0.723 | 0.753 |
| Education | ||||
| High school | 91 (23.1) | 103 (26.1) | 83 (21.1) | 89 (22.6) |
| College degree | 119 (30.2) | 133 (33.8) | 120 (30.5) | 130 (32.9) |
| Post-graduation | 93 (23.6) | 105 (26.7) | 101 (25.6) | 98 (24.9) |
| p-value | 0.876 | 0.619 | 0.089 | 0.450 |
| COVID-19 history | ||||
| Self-COVID-19 positivity | ||||
| Yes | 44 (11.2) | 47 (11.9) | 42 (10.7) | 35 (8.88) |
| No | 259 (65.7) | 294 (74.6) | 262 (66.5) | 282 (71.6) |
| p-value | 0.089 | 0.208 | 0.344 | 0.022 |
| Self-comorbidities present# | ||||
| Yes | 126 (31.9) | 140 (35.5) | 121 (30.7) | 123 (31.2) |
| No | 177 (44.9) | 201 (51.0) | 183 (46.4) | 194 (49.2) |
| p-value | 0.731 | 0.950 | 0.330 | 0.058 |
| Family members contracted COVID-19 | 93 (23.6) | 106 (26.9) | 92 (23.4) | 95 (24.1) |
| Yes | 210 (53.2) | 235 (59.6) | 212 (53.8) | 222 (56.3) |
| No | 0.853 | 0.492 | 0.878 | 0.669 |
| p-value | ||||
| Family members with comorbidities | ||||
| Yes | 94 (23.9) | 99 (25.1) | 83 (21.1) | 86 (21.8) |
| No | 209 (53.0) | 242 (61.4) | 221 (56.1) | 231 (58.6) |
| p-value | 0.022 | 0.336 | 0.480 | 0.350 |
*Developed countries included are USA, UK, Germany, Ireland, Canada, Australia, and Netherlands. Developing countries included are Pakistan, India, UAE, Turkey, Sudan, Malaysia and Egypt (https://www.un.org/en/development/desa/policy/wesp/wesp_current/2014wesp_country_classification.pdf)
#comorbidities included were diabetes mellitus, hypertension, immunosuppressive state (cancer, organ transplant), asthma, heart and lung diseases, kidney diseases or ongoing dialysis and liver dysfunction.